Kuwait Signs Agreement With BioNtech To Deliver its Pfizer Covid-19 Vaccine
The Kuwait Ministry of Health announced in a statement on its Twitter page that the ministry has signed an agreement with Germany based Vaccine Production company BioNtech To deliver Its Pfizer Vaccine.
The vaccine will be delivered to the Country after it has completed its clinical trial and has been approved by local authorities for use.
This comes after the Germany based company announced that its Vaccine can boast of a 95% effective rate in curing Covid-19.
According to the statement made by the Kuwait Ministry of health via its Twitter page, it says, “Pfizer and BioNTech are in the process of supplying Kuwait with the potential RNA-based vector BNT162 vaccine to prevent COVID-19. Vaccine supplies will arrive by the end of 2020 and early 2021 and will be subject to approval by local regulatory authorities.”
“The agreement falls under the global commitment of Pfizer and BioNTech to confront the global Covid-19 crisis. Pfizer and BioNTech began the process of obtaining regulatory approvals in November 2020 and are expected to manufacture up to 1.3 billion doses nationwide by the end of 2021.”
“We have taken all measures to receive the Covid-19 vaccine and store it in our facilities at a level A temperature of -70 °C. Citizen service is at the top of our list of priorities,” Kuwait MOH.